• Home
    Home This is where you can find all the blog posts throughout the site.
  • Categories
    Categories Displays a list of categories from this blog.
  • Tags
    Tags Displays a list of tags that have been used in the blog.
  • Bloggers
    Bloggers Search for your favorite blogger from this site.
  • Team Blogs
    Team Blogs Find your favorite team blogs here.
  • Login
    Login Login form
Joomla! Administrator

Joomla! Administrator

This is the web admin, who is probably ghost-posting for the blog writer in most cases.


“Headset” is the name of the new data analysis company started by Cy Scott, Brian Wansolich and Scott Vickers, the entrepreneurs who brought us Leafly ( If you are a cannabis enthusiast, then you are likely familiar with the app and website Leafly that provides information and reviews of different strains and retail locations.

After selling Leafly to Privateer Holdings ( in 2011 the co-founders continued to work at their startup, only recently deciding to go their own direction with Headset and fill yet another market gap in the marijuana industries. Headset will reportedly ( be a subscription service that will provide analytical information for cannabis markets all over the world, giving firms who want to expand valuable information about potential new markets. The service will only be for companies who do not actually sell marijuana, but related products or services. At this point no service such as Headset exists, and as startups from all over the nation and world are making their way toward cannabis, the co-founders are poised to corner another part of cannabis-information market.


Leafly was started in June 2010 by three friends who noticed a need for a cannabis information database and decided to go for it. “ We figured if we had this need, others would as well” Cy Scott said to Engadget ( Then last year in 2014 Leafly ran a full-page ad in the New York Times advertising it’s services and congratulating New York on passing the Compassionate Care Act.


Hits: 8076

Following up on our post on Friday, we see $NTRR (2.4%) and $NDEV (19%) moving up as other stocks fell - $NGMC (-28%) and $ETST (-7.78%)

etstEarth Science Tech, Inc. ($ETST) reached a high of $1.74 on July 17, 2015, and has declined to a near recent all time low of $0.83. The lowest price this year was $0.78 on July 16 just prior to the spike, and recent lows were around $0.81 before rising to $1.00 price values. Spikes in October of 2014 were as high as $3.46, and the company IPO'd with a price of $0.01. ETST fell 8% today from a value of $0.90 per share yesterday at closing to $0.83. Earth Science Tech specializes in ultra-high grade CBD (cannabidiol) rich hemp oil. CBD products do not contain psychoactive ingredients and are for medicinal and wellness purposes.


ngmcNext Generation Management Corp ($NGMC) is a consulting firm that acquires businesses in the retail and cultivation industry.  They also specialize in staffing and training for dispensary businesses.  NGMC has several subsidiaries including a dispensary, a consulting limited liability company, and an energy businesses acquisition company.  The stock price is down 28% today, from 0.0044 to a price of 0.0032.  The decline comes after a large spike from 0.0015 on September 4th to the high of 0.0044.


ntrrNeutraCorp Natural Sciences ($NTRR) is a research and development company with a market cap of $2.12M.  NeutraCorp recently made headlines in Yahoo Finance for providing pesticide alternatives in a way that removes the need for strong chemicals during the growing process.  NeutraCorp partners with Vertigo, a horticultural technologies copmany, Surface to Air Solutions or S2O2, specializing in air purification technology, Second Wave Ventures, a company focused on nutraceutical delivery systems, and Diamond Anvil Designs, a vapor pen design company that was acquired by NTRR in 2014.  $NTRR currently is up 2.44% from 0.035 to 0.0369.  The stock has risen from an all-time low of 0.02 to a higher platform around 0.04 with one jump to 0.05 so far.  The highest peak was in April of 2013 at a price of $2.72.

ndevNovus Acquisition & Development Corp ($NDEV) is a Nevada-based company specializing in providing healthcare and medical plans for medicinal marijuana patients.  The company has two divisions, Novus Medical Group and Novus QC.  The stock price for $NDEV began Monday morning at $0.014 and jumped at 1:05 PM to a price of $0.0174, a jump of 18.62%.  The price is still at a near all time low, after rising from 0.0035 to 0.4948 from January to August of 2014.  The decline has dropped over time to now, however the current bump does not yet demonstrate high potential for a big jump.  

Hits: 8567

Today's movers include $NTRR (+4%), $SPRWF (+18%), $NDEV (+5%), $GRNH (+10%), and $HLSPY (+29%)


neutra logo 300x94NeutraCorp Natural Sciences ($NTRR) is a research and development company with a market cap of $2.12M.  NeutraCorp recently made headlines in Yahoo Finance for providing pesticide alternatives in a way that removes the need for strong chemicals during the growing process.  NeutraCorp partners with Vertigo, a horticultural technologies copmany, Surface to Air Solutions or S2O2, specializing in air purification technology, Second Wave Ventures, a company focused on nutraceutical delivery systems, and Diamond Anvil Designs, a vapor pen design company that was acquired by NTRR in 2014.  


Supreme Portfolio Logo1 copy 1Supreme Pharmaceuticals, Inc. ($SPRWF) is a Canada-based medical marijuana marketplace.  The publicly-traded company is on the path to becoming Canada's leading medical marijuana supplier.  $SPRWF has a daily increase of 18.39% and a current price of $0.103, up from 0.085 on September 9th.  The market cap is $13.95M, the average trade volume is 54,900, and the beta value is 18.51.  The stock began around 10 cents in July of 2014, saw a peak of $0.45, and has been declining since October 22nd, 2014.  


novus logo3Novus Acquisition & Development Corp ($NDEV) is a Nevada-based company specializing in providing healthcare and medical plans for medicinal marijuana patients.  The company has two divisions, Novus Medical Group and Novus QC.  The company started with a price of $0.195 in January of 2013 and reached a peak of $0.99 on March 4th.  Since then the stock price has declined, risen again to $0.43, and then declined again to $0.0158 (the current price).  


greengro logoGreenGro Technologies ($GRNH) develops custom modular gro rooms (the vertical hydrogarden), automated light deprivation greenhouses, solar systems, and design and construction services for large grow operations.  Forbes described GreenGro as one of the 8 hottest publicly traded marijuana companies in November of 2014.  The $GRNH market cap is $5.42M with a average volume of 711,670.  The stock price started at $0.11 in February of 2013, reached a peak of $0.583 on March 10th of 2014, and has declined to a low of $0.0250 on August 10th, 2015.  The price has risen 130% to a current price of $0.047 over the past month.  

heliospectra LogoHeliospectra ($HLSPY) provides smart LED grow technology including the E60 lamp product.  Their goal is to incorporate biofeedback "where the plants are in essence controlling the light system" to maximize plant productivity.  Heliospectra's systems decrease energy consumption by 50% in greenhouses.  Focus on research and development is essential to the maintaining the momentum and HLSPY joins with other research institutes to continue to increase productivity and energy savings.  The market cap is $25.51M and experiences volatile fluctuations in stock price.  The stock has a previous close yesterday of $1.44 and has increased to $1.85 since then.  

Hits: 4238

The annual Conference of Western Attorneys General was held earlier this month where state-level officials met with representatives of the cannabis and hemp industries and called for the setting of national standards for and by those industries. The officials encouraged the businesspeople to form a self-regulating organization capable of producing guidelines for all aspects of their recently legal businesses. This meeting is unique in the American cannabis history where lawmakers are openly discussing best practices with cannabis producers.


“This felt like a watershed moment, and there were attorneys general who said that to me, in those exact words,” said Michael Bronstein of the American Association for Cannabis and Hemp.


Marijuana Business Daily reports that “A committee of public officials and industry representatives will work together to develop the code” although the article does not say who specifically will be on the committee.


Attendants of the meeting included Attorneys General from twenty districts, Dr. Cindy Orser - CSO of DigiPath Labs, Jake Salazar of MMJ America, Bob Eschino of Medically Correct, Todd Mitchem of High There, and a representative of the Coalition for Responsible Cannabis Production.

Hits: 3591


Today New York announced the five companies granted permits to manufacture cannabis products for the state’s medical marijuana program. Bloomfield Industries Inc., Columbia Care NY LLC, Empire Health Solutions and Etain LLC and PharmaCann LLC will each be allowed to produce various cannabis products and open five dispensaries across the state, allowing for a total of twenty locations statewide. While it is always good to see another state allowing citizens to use an important medicine, New York’s system may put too many restrictions on access


New York State Assemblyman Richard Gottfriend said he thought the permitting process lacked transparency and was “an open invitation to all sorts of allegations.” Forty-three companies applied for the permits, each of which paid a $10,000 application fee; the five selected will have to pay $200,000 more to get their permits. CEO of eCann Inc. Eddie Miller, suggested that some of the firms passed over for the license will sue, and there is a precedent for that kind of thing.


New York is the only state other than Minnesota to disallow smoking in their medical marijuana laws. Patients in New York will be allowed access to vaporizers, edibles and oils, they are not allowed to grow or produce their own medicine. The state’s medical marijuana law was given an “F+” in a report from American for Safe Access (ASA) titled “Medical Marijuana Access in the U.S.” Deputy Director of the Drug Policy AllianceJulie Netherland said that “given the current proposed sites, there are huge areas of the state where patients will have to travel enormous distances to get medicine."


Although flawed, this law will allow many New Yorkers legal access to a medicine that can be extremely therapeutic and in some situations life-saving, and that makes it a good thing. Supporters of New York’s law have said that public health concerns like regulations on purity and quality control are at the core of this system, something that is lacking in some medical states.


The laws and regulations around the cannabis plant are changing more rapidly now than perhaps they ever have before and medical marijuana laws in all states may very well be affected by Federal legislation coming down the pike.

Hits: 3668
Snoop Dogg has a Venture-Capital Fund for Weed

Calvin Broadus Jr. more commonly known as Snoop Dogg and recently Snoop Lion has started a venture-capital fund with the purpose of investing in cannabis-industry startups.


On Friday June 12, Casa Verde Capital filed with the Securities and Exchange Commission and Snoop was listed as a managing member.The organization will is reportedly seeking $25 million from investors and will focus on tech used within the evolving systems of the cannabis industry. This sounds like a pretty great idea when you think about how many new products have entered the cannabis-world within recent years, and how many are sure to come given the state of flux the industry is in.


Snoop obviously brings instant brand-recognition to anything he touches, especially when that thing is related to cannabis. But Snoop also brings previous experience to the table, as he is reportedly invested in a stock-trading enterprise called Robinhood, and “the homepage of the internet” Reddit.

In case you were wondering, venture-capital funds are high-risk, high-return, managed investment funds where private investors buy equity in small or starting businesses.

Hits: 3883
Cannabis legalization bills introduced at federal level

Two Bills proposing the federal legalization of cannabis were introduced to the House of Representatives June 20,2015. Two representatives each introduced bills that together would remove marijuana from all schedules of the controlled substance act and establish taxation and permitting for for recreational use and production. 

Representative Jared Polis of Colorado introduced H.R. 1013 into the House which would legalize cannabis, tranfer oversight from the Drug Enforcement Administration to the Bureau of Alcohol Tobacco and Firearms and generally set the stage for legal recreational cannabis use in the United staes. 

Representative Earl Blumenauer of Oregon introduced H.R. 1014 which would amend the Internal Revenue Code to allow for taxation of marijuana and stipulates that people must recieve permits to engage in marijuana enterprises. 

At the moment it seems that both bills would have to pass to create a functional system by which cannabis would be legal for adults in the US. But as we know bills often chenge in  the proces of becoming law; it ishard to say the future of the bills or what their consequences may be. What can be said is that this is exciting for cannabis advocates and historic for the nation.

Hits: 3583

Hemp oil is a food product made by pressing the seeds of the hemp plant to extract the oil. You can buy it at the grocery store and it contains very little to no THC or CBD. Meaning that while it is a very nutritious food, it will neither provide any medical benefits or a high to the user. It does go well with vinegar on salad or bread.

With the media frenzy around CBD and it’s exciting medical applications, google Charlotte’s web - CDB, came a vast array of “CBD rich” products with some companies shipping to all 50 states (more on that in another post). Many of these products are marketed as “Hemp Oil” which can be confusing because as we know there is already another product marketed under that name. The two products in no way resemble each-other.

CBD rich oil is made by extracting the resin from plants that produce high levels of CBD. It is usually a sticky paste that does not taste good. The plants that produce significant amounts of CBD are not the industrial hemp varieties, they much more resemble the high THC plants that have been bred to produce large amounts of cannabinoid rich resin on the leaves and flowers.

Eric Streenstra of Vote Hemp and the Industrial Hemp Association said to “Our biggest concern, from an industry standpoint, is the conflation of hemp oil and cannbidol. The reality is that the best source of CBD is high resin strains of cannabis - the drug kind.”

Although CBD is not psychoactive so to say it the cannabis plants that produce it are “the drug kind” may be a stretch, but that’s just my opinion.

So the next time that you are on Amazon, and you see one “hemp oil” product costs thirty dollars / ounce while another comes in at about sixty cents / ounce, you’ll know why.

Hits: 4131

The debate about medical cannabis use in New Zealand has come to the forefront after a teenager in Wellington Hospital was given Elixinol, a drug containing cannabis derived cannabidiol (CBD), to treat epilepticus. 20 other medications were attempted previous to Elixinol.

Alex was training to be a chef and started going into seizures after feeling low-energy for a few days. He was then placed in an induced coma for 54 days to control ongoing epileptic-like seizures. Twenty different medications were attempted, and Alex's mother fought for the right to use Elixinol. The drug was not being allowed due to the bureaucracy surrounding medical marijuana, but on June 9th the Associate Health Minister Peter Dunne approved the remedy.

Today, his first Elixinol treatments were finally administered and he stated that he feels "calm and settled" after his second treatment, according to TVNZ.

In other news, On June 15th, Auckland police have carried out 10 search warrants and arrested eight people who will be charged with selling and cultivation of marijuana. Thousands of plants were seized.

John Key, New Zealand's Prime Minister, has stated that "I haven't seen any advice that supports the view that we should be taking a broader view of the use of medical marijuana", according to NZCity.

Hits: 3805

b2ap3_thumbnail_joint-120110.jpgOn Monday, the Colorado Supreme Court ruled that Colorado businesses can fire employees that test positive for THC on their drug tests. The case that brought this ruling to light involved a Colorado man named Brandon Coats, who smoked medical marijuana to cope with paralysis problems after a car accident. He stated that his smoking weed at home did not affect his job performance. Medicinal use is still illegal under federal law and that fact drove the decision.

Federal Law on marijuana must be re-assessed. The current administration officials and attorney general, Loretta Lynch, believe in old traditional misunderstandings of marijuana as a drug that is as bad as heroine or methamphetamine. Vivek Murthy, the surgeon general of the United States of America, has a different view and understands that marijuana "can be helpful" in his interview with CBS news. Declassification of marijunana to a drug that has medicinal value would keep people like Brandon Coats working at his job. With so much momentum for recreational and medicinal marijuana going forward, this move by the Supreme Court is a significant step backward in the wrong direction.

Hits: 3709

Marijuana stocks are volatile, but high risk yields high rewards.  Here are some of the main stocks that I have been eyeballing for some time.  Most of them have been going down for some time and I am expecting that the time has come for them to once rise again.  The Marijuana Business Daily forcasts marijunana sales surging to $8B by 2019 and the amount of capital investing in marijuana companies has risen by over 900%.


Top Pick

GW Pharmaceuticals (GWPH) has been bullish since it began back in 2013.  The increase since that time has been a whopping 1,162% and 63% YTD.  GW Pharmaceuticals has been around since 1998 and has focused on drugs for medical research.  The cannibinoid component of the research has been geared towards treatments of the Central Nervous System. The current stock price is $114.11 and is down about 6% from the all time high on April 24th.  A new product is a treatment called Epidiolex that treats a form of childhood epilepsy.  


Vape Holdings, Inc. (VAPE) is founded by CEO and Chairman Kyle Tracey, a former president and co-founder of GrowLife Inc, Joseph Andreae, Allan Viernes, Benjamin Beaulieu, and Mark Scialdone, all with tons of experience in the MMJ industry.  The VAPE Holdings brands include HIVE Ceramics that produces ceramic elements for vaporizers and custom design work, HIVE Supply, and Nouveau. HIVE Ceramics that produces ceramic elements for vaporizers and custom design work.  Hive Supply provides packageing and sourcing services and is described as a "one-stop shop" for marijuana packaging necessities on their website.  Nouveau is a website design and marketing company based in LA.  The stock is currently priced at $0.52, down from high of $3.10 in July of 2014, a 82% loss.  YTD yield is down 33% but has been trending upwards of 30% since the start of May.  The market cap is $5.9M.


Growblox Sciences, Inc. (GBLX) focuses on cutting edge research and product development for medical marijuana.  Their products include vape oil, flowers (buds), lozenges, patches, and the GrowBlOX system that will enable indoor cannibus cultivation in a sterile box.  The stock is down about 7% since the start of the year and is up 129% since March 27th.  Current price is $0.39 and the market cap is $13.7M.


Medical Marijunana, Inc. (MJNA) has been conductor of the bear market train since their previous peak of $0.37 on January 31st, 2014.  The price has declined 79% to a low of $0.08.  This penny stock has been all over the news after recently coming out with a sales increase of 280% in 2014.  Medical Marijuana Inc. holds several companies including HempMeds, KannaLife, KannaWay, Canchew, Canipa Holdings, and more.  In addition, they hold products including Real Scientific Hemp Oil, Dixie Botanicals, skin care products, vape products, CBD hemp oil supplements, and the Canchew hemp gum (first in the industry).  Medical Marijuana Inc. was the first publicly held company in the marijuana industry and has a volatile past with surges in 2009, 2013, and 2014. The stock has flatlined since Tuesday and we are excitedly expecting something to happen here on Monday morning.


Hits: 10945

With 23 states allowing medical marijuana and 4 allowing recreational use (as well as the District of Columbia), the industry is booming. Not only have direct marijuana sales been so successful as to create an illegal level of tax surplus in the State of Colorado, but ancillary industries in tech, packaging and tourism have seen equally huge growth. Currently there is a wave of investment interest for promising small business and entrepreneurs prepared to take advantage of the growing market.


Granted, this market, like all others, is subject to some downturns. We already saw a major downturn in the marijuana index after a huge bubble erupted immediately after the first legalization in 2013. However, the market has since stabilized, first into a more natural downward curve before leveling off and tipping up again at natural steady growth rate that appears promising going into a long-term future.




That initial boom and bust, combined with the hazy legality has made some of the largest economic interests unwilling to jump in, but this is another advantage for small investors. Without competition from Fortune 500 companies, smaller investors are primed to reap huge profits from this steadily growing industry. While the current legal situation is complicated, we are seeing bipartisan support for federal recognition of states' right to determine their own marijuana laws: senators Gillibrand (D- New York), Booker (D- N.J.) and Paul (R- Kentucky) currently have such a bill in progress. With legality moving in the direction of public opinion and the experiments in Washington and Colorado having been so far successful, the white market in the marijuana industry is almost certainly about to see humongous growth.  

Hits: 3839